Pharma BD Deal Intelligence

Roche Holding AG / Ignyta Inc.

2017 · Acquisition/Merger · $1.7B · Complete

Announcement Sentiment

88

Strongly positive

Outcome Score

73

Largely worked — most objectives met.

Roche acquired Ignyta for ~$1.7B for cancer targeted therapies.

Key facts

Announced Dec 22, 2017
Closed Feb 23, 2018
Deal value $1.7B
Deal type Acquisition/Merger
Therapeutic area Oncology

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals